LncRNA CA12-AS1 targets miR-133a to promote LPS-induced inflammatory response in bovine mammary epithelial cells

Fen Feng,Yanxia Li,Jinpeng Wang,Yiwen Dong,Yuhang Li,Zhuoma Luoreng,Xingping Wang
DOI: https://doi.org/10.1016/j.ijbiomac.2024.129710
IF: 8.2
2024-02-02
International Journal of Biological Macromolecules
Abstract:Bovine mastitis seriously affects milk production and quality and causes huge economic losses in the dairy industry. Recent studies have shown that long non-coding RNAs (lncRNAs) may regulate bovine mastitis. In this study, the expression of lncRNA CA12-AS1 was significantly upregulated in LPS-induced bovine mammary epithelial cells (bMECs) but negatively correlated with the expression of miR-133a, suggesting that it may be related to the inflammatory response in bMECs. Dual luciferase reporter gene assay revealed that miR-133a is a downstream target gene of lncRNA CA12-AS1. Furthermore, lncRNA CA12-AS1 silencing negatively regulated the expression of miR-133a inhibited the secretion of inflammatory factors (IL-6, IL-8 and IL-1β) and decreased the mRNA expression levels of nuclear factor kappa B ( NF-κB ) ( p65/p50 ) and apoptosis-related genes ( BAX , caspase3 and caspase9 ). LncRNA CA12-AS1 silencing also promoted the mRNA expression levels of the Tight junction (TJ) signaling pathway-related genes ( Claudin-1 , Occludin and ZO-1 ), apoptotic gene BCL2 , proliferation-related genes ( CDK2 , CDK4 and PCNA ) and the viability of bMECs. However, overexpression of lncRNA CA12-AS1 reversed the above effects. These results revealed that lncRNA CA12-AS1 is a pro-inflammatory regulator, and its silencing can alleviate bovine mastitis by targeting miR-133a, providing a novel strategy for molecular therapy of cow mastitis.
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?